Aeovian Pharmaceuticals

Developer of therpeutics for treating rare diseases

placeSan Francisco, California, United States calendar_todayFounded 2012 groups10 employees language aeovian.com

Registered entities

Innovation

6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 590 times.

YearFilings
20201
20212
20223
20234
20243
20254
20264

Social engagement

Social engagement: 1.9K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Hevolution, Sofinnova Investments, VenBio, Luma Group.

Investor typeCountShare
Venture capital1059%
Private equity16%
Other / undisclosed635%
Coming soon